| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0002 |
| mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.0002 |
| mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.004 |
| mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.005 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |